Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Clinical trial NCT00085423 · COMPLETED

Trial details

NCT number: NCT00085423
Sponsor: Dartmouth-Hitchcock Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2004-02-01
Primary completion: 2008-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.